NCT03878511View on ClinicalTrials.gov

Therapeutic Lactose to Support Vaginal Microbiota

NACompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

November 1, 2012

Primary Completion Date

March 1, 2013

Study Completion Date

March 1, 2013

Conditions
Bacterial Vaginoses
Interventions
DIETARY_SUPPLEMENT

Lactose

Lactose monohydrate 810 mg, silicon dioxide 20 mg, and magnesium stearate 14 mg

DIETARY_SUPPLEMENT

Placebo

Dextran 40 EP 671 mg, silicon dioxide 20 mg and magnesium stearate 14 mg

All Listed Sponsors
lead

Peter Humaidan

OTHER

NCT03878511 - Therapeutic Lactose to Support Vaginal Microbiota | Biotech Hunter | Biotech Hunter